Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PRA Health Sciences Inc. PRAH

PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In... see more

Recent & Breaking News (NDAQ:PRAH)

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Buyout Investigation

GlobeNewswire March 4, 2021

ALERT: Halper Sadeh LLP Investigates WIFI, PRAH, PAND, CTB; Shareholders are Encouraged to Contact the Firm

PR Newswire March 4, 2021

Lifshitz Law Firm, P.C. Announces Investigation of APEX, CTB, GT, FRTA, PAND, PRAH, ICLR, PBCT and MBT

PR Newswire March 1, 2021

PRA HEALTH SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of PRA Health Sciences, Inc. - PRAH

Business Wire March 1, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates PAND, PRAH, FFG, CTB; Shareholders Are Encouraged to Contact the Firm

GlobeNewswire March 1, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of PRA Health Sciences, Inc. - PRAH

PR Newswire February 27, 2021

Moore Kuehn Encourages SFTW, PRAH, RTP, and PAND Investors to Contact Law Firm

GlobeNewswire February 26, 2021

INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PAND, PRAH, AEGN, PTVCA, CRHM, CBLI, AKER

PR Newswire February 25, 2021

SHAREHOLDER ALERT: WeissLaw LLP Investigates PRA Health Sciences Inc.

PR Newswire February 24, 2021

Shareholder Alert: Ademi LLP Investigates whether PRA Health Sciences, Inc. has obtained a Fair Price in its transaction with Icon

PR Newswire February 24, 2021

PRA HEALTH SCIENCES ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PRAH and Encourages Investors to Contact the Firm

GlobeNewswire February 24, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of PRA Health Sciences, Inc. Buyout

GlobeNewswire February 24, 2021

PRA Health Sciences Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of PRA Health Sciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - PRAH

Business Wire February 24, 2021

(PRAH): Johnson Fistel Investigates the Proposed Sale of PRA Health; Are Shareholders Getting a Fair Deal?

PR Newswire February 24, 2021

PRA Health Sciences, Inc. Reports Fourth Quarter and Full Year 2020 Results

GlobeNewswire February 24, 2021

ICON to Acquire PRA Health Sciences, Creating a World Leader in Healthcare Intelligence and Clinical Research

Business Wire February 24, 2021

PRA Health Sciences to Report Fourth Quarter and Full Year 2020 Earnings

GlobeNewswire February 4, 2021

PRA Health Sciences collaborates with PWNHealth and Fulgent Genetics to provide at-home COVID-19 test capabilities

GlobeNewswire December 17, 2020

PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy

GlobeNewswire November 19, 2020

PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 Guidance

GlobeNewswire November 4, 2020